Acute Decompensated Heart Failure

Cardiology

Illness script · Cardiology

Acute Decompensated Heart Failure

Sudden worsening of HF symptoms causing fluid overload and/or low cardiac output requiring urgent hospitalization.

This illness script for Acute Decompensated Heart Failure covers predisposing factors, classic presentation, mechanism, workup, management, and the clinical pivots that separate it from look-alikes—written for USMLE Step 1 and clerkship reasoning.

Updated Jul 19, 2026All scripts

01

Predisposing factors

  • Most common cause of hospitalization in adults >65 years
  • Underlying HFrEF (EF <40%) or HFpEF (EF ≥50%, hypertension-driven)
  • Key precipitants: medication/dietary nonadherence, ACS, AF, infection, uncontrolled HTN
  • Other triggers: new nephrotoxins (NSAIDs), anemia, thyroid disease
  • Risk factors: HTN, CAD, DM, obesity, prior HF, valvular disease

02

Presentation

  • Acute dyspnea (orthopnea, PND) ± frothy pink sputum in flash pulmonary edema
  • Bilateral crackles, S3 gallop, JVD, pitting edema — classic exam triad of overload
  • Hepatojugular reflux positive; displaced PMI suggests dilated cardiomyopathy
  • Weight gain >2 kg over days is a sensitive early sign
  • Cold/clammy extremities + hypotension = cardiogenic shock (low-output state)
  • Bendopnea (dyspnea bending forward) specific for elevated filling pressures

03

Pathophysiology

  • ↑ ventricular filling pressures → pulmonary venous congestion → pulmonary edema
  • Reduced CO activates RAAS and SNS → Na/water retention → worsening congestion
  • Neurohormonal activation (↑ BNP, ↑ norepinephrine) is both marker and driver of decompensation
  • Cardiorenal syndrome: ↓ renal perfusion compounds fluid retention

04

Diagnostics

  • CXR first-line: pulmonary vascular congestion, Kerley B lines, cardiomegaly, pleural effusions
  • BNP >400 pg/mL (NT-proBNP >1000) strongly supports HF vs. pulmonary cause of dyspnea
  • BNP 100–400: intermediate — consider PE, cor pulmonale, renal failure
  • Echo: confirms EF, wall motion, valvular pathology — defines HFrEF vs. HFpEF
  • ECG + troponin to exclude ACS as precipitant; BMP for renal function/electrolytes

05

Management

  • IV loop diuretics (furosemide) first-line: IV dose = 2.5× home oral dose if on chronic therapy
  • IV nitroglycerin for afterload/preload reduction in hypertensive pulmonary edema
  • Non-invasive ventilation (BiPAP/CPAP) for refractory hypoxia — reduces intubation rates
  • Hold/down-titrate beta-blockers during acute decompensation; restart before discharge
  • Cardiogenic shock: IV inotropes (dobutamine) ± vasopressors; consider IABP/LVAD
  • Identify and treat precipitant (rate-control AF, revascularize if ACS, antibiotics if sepsis)

06

Clinical pivots

How to separate this script from the look-alikes that show up on exams and on the wards.

  • Pneumonia / ARDS

    BNP normal/low; fever + productive cough; CXR infiltrates non-gravity-dependent; no JVD or S3

  • COPD/Asthma Exacerbation

    Expiratory wheeze, barrel chest, no JVD; CXR hyperinflation; BNP normal; responds to bronchodilators

  • Pulmonary Embolism

    Acute RV strain on ECG (S1Q3T3); BNP mildly elevated; CXR often clear; CT-PA diagnostic

  • Cardiac Tamponade

    Beck's triad (hypotension, JVD, muffled hearts); pulsus paradoxus; echo shows pericardial effusion + RV collapse

View full library

Educational use only. This illness script is a study framework, not medical advice. Confirm decisions with current guidelines and your clinical supervisors.